38 related articles for article (PubMed ID: 10778978)
1. Spontaneous T cell responses to melanoma differentiation antigens from melanoma patients and healthy subjects.
Chen Q; Jackson H; Gibbs P; Davis ID; Trapani J; Cebon J
Cancer Immunol Immunother; 1998 Dec; 47(4):191-7. PubMed ID: 9875671
[TBL] [Abstract][Full Text] [Related]
2. PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting.
Labarrière N; Gervois N; Bonnin A; Bouquié R; Jotereau F; Lang F
Cancer Immunol Immunother; 2008 Feb; 57(2):185-95. PubMed ID: 17646986
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose.
Lövgren T; Baumgaertner P; Wieckowski S; Devêvre E; Guillaume P; Luescher I; Rufer N; Speiser DE
Cancer Immunol Immunother; 2012 Jun; 61(6):817-26. PubMed ID: 22080404
[TBL] [Abstract][Full Text] [Related]
4. Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes.
Fossati G; Balsari A; Taramelli D; Sensi ML; Pellegris G; Nava M; Parmiani G
Cancer Immunol Immunother; 1982; 14(2):99-104. PubMed ID: 6965234
[TBL] [Abstract][Full Text] [Related]
5. Lack of suppressive activity of human primary melanoma cells on the activation of autologous lymphocytes.
Taramelli D; Mazzocchi A; Clemente C; Fossati G; Parmiani G
Cancer Immunol Immunother; 1988; 26(1):61-6. PubMed ID: 3345538
[TBL] [Abstract][Full Text] [Related]
6. Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer.
Ducoin K; Oger R; Bilonda Mutala L; Deleine C; Jouand N; Desfrançois J; Podevin J; Duchalais E; Cruard J; Benlalam H; Labarrière N; Bossard C; Jarry A; Gervois-Segain N
Oncoimmunology; 2022; 11(1):2046931. PubMed ID: 35295095
[TBL] [Abstract][Full Text] [Related]
7. The calcium-binding protein S100B reduces IL6 production in malignant melanoma via inhibition of RSK cellular signaling.
Alasady MJ; Terry AR; Pierce AD; Cavalier MC; Blaha CS; Adipietro KA; Wilder PT; Weber DJ; Hay N
PLoS One; 2021; 16(8):e0256238. PubMed ID: 34411141
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic features of tumour-infiltrating CD4
Parrot T; Oger R; Allard M; Desfrançois J; Raingeard de la Blétière D; Coutolleau A; Preisser L; Khammari A; Dréno B; Delneste Y; Guardiola P; Fradin D; Gervois N
Sci Rep; 2020 Apr; 10(1):5900. PubMed ID: 32246006
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory receptor CD94/NKG2A on CD8
Eugène J; Jouand N; Ducoin K; Dansette D; Oger R; Deleine C; Leveque E; Meurette G; Podevin J; Matysiak T; Bennouna J; Bezieau S; Volteau C; Thomas WEA; Chetritt J; Kerdraon O; Fourquier P; Thibaudeau E; Dumont F; Mosnier JF; Toquet C; Jarry A; Gervois N; Bossard C
Mod Pathol; 2020 Mar; 33(3):468-482. PubMed ID: 31409873
[TBL] [Abstract][Full Text] [Related]
10. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4
Parrot T; Oger R; Benlalam H; Raingeard de la Blétière D; Jouand N; Coutolleau A; Preisser L; Khammari A; Dréno B; Guardiola P; Delneste Y; Labarrière N; Gervois N
Oncoimmunology; 2016; 5(12):e1250991. PubMed ID: 28123891
[TBL] [Abstract][Full Text] [Related]
11. PD-1 expression conditions T cell avidity within an antigen-specific repertoire.
Simon S; Vignard V; Florenceau L; Dreno B; Khammari A; Lang F; Labarriere N
Oncoimmunology; 2016; 5(1):e1104448. PubMed ID: 26942093
[TBL] [Abstract][Full Text] [Related]
12. High efficiency ex vivo cloning of antigen-specific human effector T cells.
Neller MA; Lai MH; Lanagan CM; O'Connor LE; Pritchard AL; Martinez NR; Schmidt CW
PLoS One; 2014; 9(11):e110741. PubMed ID: 25368986
[TBL] [Abstract][Full Text] [Related]
13. A full GMP process to select and amplify epitope-specific T lymphocytes for adoptive immunotherapy of metastatic melanoma.
Labarriere N; Fortun A; Bellec A; Khammari A; Dreno B; Saïagh S; Lang F
Clin Dev Immunol; 2013; 2013():932318. PubMed ID: 24194775
[TBL] [Abstract][Full Text] [Related]
14. MELOE-1 antigen contains multiple HLA class II T cell epitopes recognized by Th1 CD4+ T cells from melanoma patients.
Bobinet M; Vignard V; Rogel A; Khammari A; Dreno B; Lang F; Labarriere N
PLoS One; 2012; 7(12):e51716. PubMed ID: 23284752
[TBL] [Abstract][Full Text] [Related]
15. HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.
Allard M; Tonnerre P; Nedellec S; Oger R; Morice A; Guilloux Y; Houssaint E; Charreau B; Gervois N
PLoS One; 2012; 7(11):e50951. PubMed ID: 23226431
[TBL] [Abstract][Full Text] [Related]
16. Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas.
Desfrançois J; Moreau-Aubry A; Vignard V; Godet Y; Khammari A; Dréno B; Jotereau F; Gervois N
PLoS One; 2010 Jan; 5(1):e8437. PubMed ID: 20052413
[TBL] [Abstract][Full Text] [Related]
17. MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.
Godet Y; Moreau-Aubry A; Guilloux Y; Vignard V; Khammari A; Dreno B; Jotereau F; Labarriere N
J Exp Med; 2008 Oct; 205(11):2673-82. PubMed ID: 18936238
[TBL] [Abstract][Full Text] [Related]
18. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.
Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY
Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068
[TBL] [Abstract][Full Text] [Related]
19. High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells.
Gervois N; Labarriere N; Le Guiner S; Pandolfino MC; Fonteneau JF; Guilloux Y; Diez E; Dreno B; Jotereau F
Clin Cancer Res; 2000 Apr; 6(4):1459-67. PubMed ID: 10778978
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
